Filing Details
- Accession Number:
- 0001237899-13-000051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-20 16:25:35
- Reporting Period:
- 2013-09-18
- Filing Date:
- 2013-09-20
- Accepted Time:
- 2013-09-20 16:25:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1218629 | S Leonard Schleifer | 777 Old Saw Mill River Road Tarrytown NY 10591 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-18 | 218,389 | $9.49 | 260,476 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-18 | 6,808 | $304.38 | 253,668 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2013-09-18 | 108,632 | $304.38 | 145,036 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2013-09-19 | 36,334 | $300.33 | 108,702 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 15,611 | $301.45 | 93,091 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 15,625 | $302.68 | 77,466 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 5,103 | $303.38 | 72,363 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 10,645 | $304.36 | 61,718 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 7,026 | $305.50 | 54,692 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 7,248 | $306.47 | 47,444 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 1,157 | $307.20 | 46,287 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 1,200 | $308.70 | 45,087 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 1,200 | $309.80 | 43,887 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 1,800 | $310.14 | 42,087 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-18 | 218,389 | $0.00 | 218,389 | $9.49 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2013-09-18 | 6,808 | $0.00 | 6,808 | $304.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-12-15 | No | 4 | M | Direct | |
| 6,808 | 2014-03-18 | 2014-12-15 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,618 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 36,334 shares of Company stock on September 19, 2013 at prices ranging from $300.00 to $300.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 15,611 shares of Company stock on September 19, 2013 at prices ranging from $301.00 to $301.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 15,625 shares of Company stock on September 19, 2013 at prices ranging from $302.00 to $302.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 5,103 shares of Company stock on September 19, 2013 at prices ranging from $303.00 to $303.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 10,645 shares of Company stock on September 19, 2013 at prices ranging from $304.03 to $304.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 7,026 shares of Company stock on September 19, 2013 at prices ranging from $305.00 to $305.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 7,248 shares of Company stock on September 19, 2013 at prices ranging from $306.00 to $306.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 1,157 shares of Company stock on September 19, 2013 at prices ranging from $307.00 to $307.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 1,200 shares of Company stock on September 19, 2013 at prices ranging from $309.72 to $309.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 1,800 shares of Company stock on September 19, 2013 at prices ranging from $310.00 to $310.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
